Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice

Journal of Gastroenterology

Volumn 39, Issue 9, 2004, Pages 867-872

  Mimura, Sumie ^a   Mochida, Satoshi ^a   Inao, Mie ^a   Matsui, Atsushi ^a   Nagoshi, Sumiko ^a   Yoshimoto, Takayuki ^b   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Concanavalin A; IFN ; IL 10; Osteopontin; Transgenic mouse

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; OSTEOPONTIN; SERUM AMYLOID P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE VECTOR; HISTOPATHOLOGY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER NECROSIS; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STELLATE CELL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ANIMALS; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, CELLULAR; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NECROSIS; OSTEOPONTIN; SIALOGLYCOPROTEINS; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 6944238472     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1403-0     Document Type: Article

References (27)

1. Mochida S, Fujiwara K. Symposium on clinical aspects in hepatitis virus infection. 2. Recent advances in acute and fulminant hepatitis in Japan. Intern Med 2001;40:175-7.
2. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977;73:639-45.
3. Kimura K, Ando K, Tomita E, Ohnishi H, Ishikawa T, Kakumu S, et al. Elevated intracellular IFN-γ levels in circulating CD8+ lymphocytes in patients with fulminant hepatitis. J Hepatol 1999; 31:579-83.
4. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, et al. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 2002;36:1001-8.
5. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, et al. Perform, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997;158:5283-91.
6. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993;178:1541-54.
7. Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated hepatic macrophages in rat liver necrosis. Gastroenterology 1993;104:1466-71.
8. Mochida S, Arai M, Ohno A, Fujiwara K. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 1999;29:1532-40.
9. Butler WT. The nature and significance of osteopontin. Connect Tissue Res 1989:123-36.
10. Uede T, Katagiri Y, Iizuka J, Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol Immunol 1997;41:641-8.
11. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and marine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 1990;71:1931-42.
12. Murry CE, Giachelli CM, Schwartz SM, Vracko R. Macrophages express osteopontin, during repair of myocardial necrosis. Am J Pathol 1994;145:1450-62.
13. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287:860-4.
14. Kawashima R, Mochida S, Matsui A, YouLuTuz Y, Ishikawa K, Toshima K, et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 1999;256:527-31.
15. Wang Y, Mochida S, Kawashima R, Inao M, Matsui A, YouLuTuz Y, et al. Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. J Gastroenterol 2000;35:696-701.
16. Mochida S, Yoshimoto T, Mimura S, Inao M, Matsui A, Ohno A, et al. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem Biophys Res Commun 2004;317:114-20.
17. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
18. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000;157:1671-83.
19. Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995;109:166-76.
20. Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996;111:462-71.
21. Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, et al. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997;25:1382-9.
22. Di Marco R, Xiang M, Zaccone P, Leonardi C, Franco S, Meroni P, et al. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 1999;31:75-83.
23. Kato M, Ikeda N. Matsushita E, Kaneko S, Kobayashi K. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanavalin-A. Hepatol Res 2001;20:232-43.
24. Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 2000;32:728-33.
25. Takamoto S, Nakamura K, Yoneda M, Makino I. Gender related differences in concanavalin A-induced liver injury and cytokine production in mice. Hepatol Res 2003;27:221-9.
26. Mizuhara H, Kuno M, Seki N, Yu WG, Yamaoka M, Yamashita M, et al. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology 1998;27:513-9.
27. Morikawa H, Hachiya K, Mizuhara H, Fujiwara H, Nishiguchi S, Shiomi S, et al. Sublobular veins as the main site of lymphocyte adhesion/transmigration and adhesion molecule expression in the porto-sinusoidal-hepatic venous system during concanavalin-A-induced hepatitis in mice. Hepatology 2000;31:83-94.